Expect Equity LLC’s Haemonetics HAE Stock Holding History

Expect Equity LLC’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.08M	Buy	41,026 +4,000	+11%	+$257K	1.98%	18
2026 Q1	$2.09M	Buy	37,026 +5,645	+18%	+$368K	1.62%	29
2025 Q4	$2.52M	Buy	31,381 +457	+1%	+$30.7K	2.07%	19
2025 Q3	$1.51M	Buy	30,924 +9,700	+46%	+$600K	1.47%	32
2025 Q2	$1.58M	Buy	21,224 +3,024	+17%	+$200K	1.69%	33
2025 Q1	$1.16M	Buy	18,200 +4,100	+29%	+$279K	1.3%	39
2024 Q4	$1.1M	Buy	+14,100	New	+$1.13M	1.15%	39

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Expect Equity LLC's HAE Position: Q2 2026 in Review

Expect Equity LLC increased its Haemonetics (HAE) stake by 11% in Q2 2026, buying an estimated $257K and bringing the position to 41,026 shares worth $3.08M. The position accounts for 1.98% of the portfolio, ranked #18.

Expect Equity LLC first reported a position in HAE in Q4 2024 and has held it in 7 quarters since. 330 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

Expect Equity LLC held 41,026 shares of Haemonetics worth $3.08M as of Q2 2026.
Expect Equity LLC bought 4,000 Haemonetics shares in Q2 2026, an estimated $257K.
Haemonetics made up 1.98% of Expect Equity LLC's portfolio in Q2 2026, its #18 holding.
Expect Equity LLC first reported a position in Haemonetics in Q4 2024 and has held it in 7 quarters since.
330 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Expect Equity LLC's 13F filing for Q2 2026, filed 14 Aug 2026.